Drug-induced fatty liver disease: An overview of pathogenesis and management

Journal Title: Annals of Hepatology - Year 2015, Vol 14, Issue 6

Abstract

Over the past decades, many drugs have been identified, that can potentially induce steatohepatitis in the predisposed individual. Classically this has been incriminated to amiodarone, perhexiline, and 4,4’-diethylaminoethoxyhexestrol (DH), all of which have been found to independently induce the histologic picture of non-alcoholic steatohepatitis (NASH). Pathogenetic mechanisms of hepatotoxicity although still evolving, demonstrate that mitochondrial dysfunction, deranged ATP production and fatty acid catabolism likely play an important role. Drugs like steroid hormones can exacerbate the pathogenetic mechanisms that lead to NASH, and other drugs like tamoxifen, cisplatin and irenotecan have been shown to precipitate latent fatty liver as well. Further research aiming to elucidate the pathogenesis of drug-induced steatosis and steatohepatitis is needed in order to better design therapeutic targets.

Authors and Affiliations

Sanjaya Satapathy, Vanessa Kuwajima, Jeffrey Nadelson, Omair Atiq, Arun Sanyal

Keywords

Related Articles

Evaluation of liver diseases in Iranian patients with primary antibody deficiencies

Introduction. Patients with primary antibody deficiency (PAD) can complicate with liver disease. This study was performed in order to study the prevalence and causes of hepatobiliary diseases in Iranian patients with PAD...

Pathophysiological basis of albumin use in cirrhosis

During the course of cirrhosis, a progressive reduction of splanchnic vascular resistance takes place in parallelwith a deterioration of cardiac function manifested by the disappearance of the hyperdynamic circulation du...

HAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil

Background. Patients with chronic HCV infection and superinfection by hepatitis A virus (HAV) or hepatitis B virus (HBV) have higher morbidity and mortality when compared with those without HCV infection. Therefore, HAV...

Factors affecting screening for hepatocellular carcinoma

Background and aim. Hepatocellular carcinoma (HCC) is a frequent cancer. Its prognosis is highly dependent on early diagnosis. Patients at risk for developing HCC should be enrolled in a surveillance programme. Neverthel...

Rapid identification system of frontal dysfunction in subclinical hepatic encephalopathy

Introduction and aim. Liver disease is associated with cognitive dysfunction also at early stages, and minimal hepatic encephalopathy, affecting 20-70% of patients, is frequently under-recognized. The main purpose of th...

Download PDF file
  • EP ID EP78509
  • DOI 10.5604/16652681.1171749
  • Views 119
  • Downloads 0

How To Cite

Sanjaya Satapathy, Vanessa Kuwajima, Jeffrey Nadelson, Omair Atiq, Arun Sanyal (2015). Drug-induced fatty liver disease: An overview of pathogenesis and management. Annals of Hepatology, 14(6), 789-806. https://europub.co.uk/articles/-A-78509